Lobbying activity

Q1

THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $20,000.00 income

Health Issues

View → Q1

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

FORBES-TATE for NOVARTIS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → 1A

HARNED STRATEGIES LLC for JOB CREATORS NETWORK

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $5,250.00 income

Labor Issues/Antitrust/Workplace, Food Industry (safety, labeling, etc.), Budget/Appropriations, Education

View → Q1

HARNED STRATEGIES LLC for JOB CREATORS NETWORK

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $5,250.00 income

Budget/Appropriations, Education, Trade (domestic/foreign), Health Issues

View → Q1

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q1

LUNDBECK LLC for LUNDBECK LLC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q1

ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income

Health Issues

View → Q1

PUBLIC CITIZEN for PUBLIC CITIZEN

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products

View → Q1

ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS

1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · House · Senate · $25,000.00 income

Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code

View → Q3

TODD STRATEGY GROUP for PFIZER INC.

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)

View → Q2

TODD STRATEGY GROUP for PFIZER INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income

Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)

View → 2A

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → 3A

NOVARTIS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → 2A

NOVARTIS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → 2A

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Budget/Appropriations

View → 4A

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q4

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q4

TODD STRATEGY GROUP for NOVARTIS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q4

EMD SERONO, INC. for EMD SERONO INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q4

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q4

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q4

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q4

NOVARTIS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues

View →